Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioventus (BVS) Divestments (2023)

Bioventus (BVS) has disclosed Divestments for 2 consecutive years, with -$46.4 million as the latest value for Q4 2023.

  • For the quarter ending Q4 2023, Divestments changed N/A year-over-year to -$46.4 million, compared with a TTM value of -$46.4 million through Sep 2024, down 232.97%, and an annual FY2023 reading of -$11.5 million, up 89.03% over the prior year.
  • Divestments was -$46.4 million for Q4 2023 at Bioventus, down from $46.4 million in the prior quarter.
  • Across five years, Divestments topped out at $46.4 million in Q3 2023 and bottomed at -$104.8 million in Q4 2022.